Interviews

McMaster Perspective more

Cardiology more

Endocrinology more

Gastroenterology more

  • <i>H pylori</i> eradication and allergy to metronidazole or fluoroquinolones
    H pylori eradication and allergy to metronidazole or fluoroquinolones
    What treatment regimen should be used for Helicobacter pylori eradication in patients with allergy to metronidazole or with allergy to fluoroquinolones (as the first choice and in case of initial treatment failure)?
  • High-dose dual therapy for <i>H pylori</i>
    High-dose dual therapy for H pylori
    High-dose amoxicillin–PPI dual therapy is cheaper and easy to perform. Can it be used as the first-choice regimen for Helicobacter pylori eradication in countries with high rates of bacterial resistance to clarithromycin?

Hematology more

  • Homocysteine and <i>MTHFR</i> polymorphism testing in suspected thrombophilia
    Homocysteine and MTHFR polymorphism testing in suspected thrombophilia
    Should homocysteine and MTHFR polymorphism testing be performed in patients with suspected thrombophilia?
  • Testing for rare causes of thrombophilia
    Testing for rare causes of thrombophilia
    In what situations should we perform additional testing for thrombophilia in patients without antiphospholipid syndrome and without any of the 5 basic congenital thrombophilias? What tests to order? Should they include the activity of coagulation factors VIII, IX, and X, and evaluation of the fibrinolytic system (TAFI, plasminogen, PAI-1 activity)?

ICU & Emergencies more

Infectious Diseases more

Nephrology more

Neurology more

Oncology more

Respirology more

  • LAMA and ICS in moderate asthma
    LAMA and ICS in moderate asthma
    Is it possible to use a long-acting muscarinic antagonist (LAMA) with an inhaled corticosteroid (ICS) instead of a long-acting beta2-agonist (LABA) and ICS in patients with asthma requiring GINA step 3 treatment?
  • Reliever medications in asthma: ICS and formoterol
    Reliever medications in asthma: ICS and formoterol
    How to tell which patients will benefit most from the combination of low-dose inhaled corticosteroids (ICS) and formoterol used as needed?

Rheumatology more

Toxicology more

VTE more

Other more

We would love to hear from you

Comments, mistakes, suggestions?

We use cookies to ensure you get the best browsing experience on our website. Refer to our Cookies Information and Privacy Policy for more details.